Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of metformin on systemic lupus erythematosus activity
IRCT20220817055730N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in systemic lupus erythematosus (SLE), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
metformin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on IRCT20220817055730N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220817055730N1.